What is the current Global Phage Therapy Industry market size?

The Global Phage Therapy Industry market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Global Phage Therapy Industry market?

Key drivers include rising antibiotic resistance and growing awareness of phage therapy benefits.

What are the major challenges facing the Global Phage Therapy Industry market?

Challenges include regulatory frameworks and limited awareness among healthcare professionals.

Which regions are leading the Global Phage Therapy Industry market?

North America and Europe are currently leading the market due to strong research initiatives.

Who are the top companies in the Global Phage Therapy Industry market?

Top companies include Phage Therapeutics and Armata Pharmaceuticals, driving innovation and growth.

What future opportunities exist for the Global Phage Therapy Industry market?

Future opportunities include expanding applications and increasing adoption in emerging markets.

How will technology impact the Global Phage Therapy Industry market future outlook?

Advances in technology will improve production efficiency and drive down costs, enhancing market growth.

What is the current regulatory landscape for the Global Phage Therapy Industry market?

The regulatory landscape is evolving, with ongoing efforts to establish clear guidelines and standards.

How will the Global Phage Therapy Industry market address ongoing challenges and opportunities?

The market will address challenges through increased research and development, and strategic collaborations.

Which Companies Lead the Global Phage Therapy Industry Market in 2026?

Global Phage Therapy Industry by Therapy Type (Monophage Therapy, Phage Cocktails, Engineered/Synthetic Phages, Other Phage-based Modalities), by Application (Infectious Disease Treatment (Human Health), Veterinary Applications, Food Safety & Agriculture, Environmental Applications (e.g., bioremediation), Other Applications (diagnostics, microbiome modulation)), by Route of Administration (Oral, Topical, Injectable, Other Routes (inhalation, nasal, etc.)), by End-User (Hospitals & Specialty Clinics, Research Institutes & Academic Centers, Veterinary Clinics & Animal Health Providers, Other End-Users), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $86.3 USD billion

CAGR: 17.2%

Historical Range: 2020 - 2025

Dec 25, 2025Updated: Jun 8, 2026

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $86.3 USD billion

CAGR: 17.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Global Phage Therapy Industry Market Size | CAGR 17.2 Forecast 2033

Which Companies Lead the Global Phage Therapy Industry Market in 2026?

🏭 Healthcare🌍 Global

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $86.3 USD billion

CAGR: 17.2%

Historical Range: 2020 - 2025

Dec 25, 2025Updated: Jun 8, 2026

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $86.3 USD billion

CAGR: 17.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Global Phage Therapy Industry Market Overview

The Global Phage Therapy Industry market refers to the application of bacteriophages, or phages, to treat bacterial infections. As the Global Phage Therapy Industry market size is estimated to be around $72 million, the growth outlook and market forecast indicate a significant industry expansion, driven by increasing antibiotic resistance and the need for alternative treatments. The scope of this market encompasses various types of phage therapies, including lytic phages, temperate phages, and phage-derived products, used in applications such as human health, animal health, and agriculture. With a current market size of $72 million, the Global Phage Therapy Industry market is poised for substantial growth, with a forecasted compound annual growth rate (CAGR) of 12.2% from 2026 to 2033.

Loading chart…

Key forces shaping the industry include technology shifts towards more targeted and effective phage therapies, regulatory frameworks that support the development and approval of phage-based treatments, and consumer behavior driven by increasing awareness of the need for alternative approaches to antibiotic resistance. The largest region in the Global Phage Therapy Industry market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by growing demand for innovative treatments and expanding healthcare infrastructure. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities and drive growth in this dynamic industry.

Report Overview

Report Attribute	Details
Market size value in 2025	86.30 billion
Revenue forecast in 2033	307.21 billion
Growth rate	CAGR of 17.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Therapy Type, Application, Route of Administration, End-User
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Armata Pharmaceuticals, Inc.; Adaptive Phage Therapeutics, Inc.; Pherecydes Pharma; Intralytix, Inc.; Locus Biosciences, Inc.; Micreos B.V.; Eliava Biopreparations Ltd.; PhagePro Inc.; EnBiotix, Inc.; Technophage SA; Fixed-Phage Ltd.; iNtODEWORLD; Proteon Pharmaceuticals S.A.; Phagelux Inc.; AmpliPhi Biosciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Global Phage Therapy Industry market is poised for significant growth, driven by various factors. The market dynamics are shaped by a complex interplay of growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Increasing antimicrobial resistance and the need for alternative treatments are driving the adoption of phage therapy, thereby contributing to the growth of the Global Phage Therapy Industry market size.

Advances in phage engineering and the development of more effective phage-based therapies are expected to fuel the growth forecast of the Global Phage Therapy Industry market in the coming years.

Restraints2 items

The high cost of development and the limited understanding of phage biology are significant restraints hindering the growth of the Global Phage Therapy Industry market.

The lack of a clear regulatory framework for phage therapy is another major restraint, making it challenging for companies to navigate the market and achieve a significant growth forecast.

Opportunities2 items

The increasing demand for personalized medicine and the potential of phage therapy to offer tailored treatments present significant opportunities for growth in the Global Phage Therapy Industry market.

The growing awareness of phage therapy among healthcare professionals and patients is expected to drive the adoption of phage-based treatments, thereby expanding the Global Phage Therapy Industry market size.

Challenges2 items

The scalability of phage production is a major challenge, as it requires significant investments in infrastructure and technology to meet the growing demand for phage-based therapies.

The standardization of phage therapy protocols is another challenge, as it is essential to ensure the consistency and efficacy of phage-based treatments, which will impact the growth forecast of the Global Phage Therapy Industry market.

Market Segmentation

Loading chart…

The Therapy Type segment in the Global Phage Therapy Industry market refers to the different types of phage therapies used to treat various diseases. This segment includes lytic phage therapy, lysogenic phage therapy, and temperate phage therapy, among others. Each type of therapy has its own unique characteristics and is used to target specific bacterial infections, contributing to the overall market size of the Global Phage Therapy Industry.

The Application segment in the Global Phage Therapy Industry market is divided into human therapy and animal therapy. Human therapy includes the use of phage therapy to treat diseases such as pneumonia, septicemia, and skin infections, while animal therapy involves the use of phage therapy to treat diseases in animals, such as mastitis in cattle. Understanding the Global Phage Therapy Industry segmentation by application is crucial for market analysis and growth projections.

The Route of Administration segment in the Global Phage Therapy Industry market refers to the different methods by which phage therapy is administered to patients. This includes oral administration, topical administration, intravenous administration, and inhalation, among others. Each route of administration has its own advantages and disadvantages, and the choice of route depends on the type of disease being treated and the severity of the infection.

The End-User segment in the Global Phage Therapy Industry market includes hospitals, clinics, research institutes, and pharmaceutical companies. Each end-user segment has its own unique requirements and contributes to the overall market size of the Global Phage Therapy Industry. Understanding the market taxonomy and Global Phage Therapy Industry segmentation by end-user is essential for developing effective marketing strategies and predicting market trends.

Global Phage Therapy Industry Segmentation Breakdown21 items

Therapy Type

Monophage Therapy

Phage Cocktails

Engineered/Synthetic Phages

Other Phage-based Modalities

Application

Infectious Disease Treatment (Human Health)

Veterinary Applications

Food Safety & Agriculture

Environmental Applications (e.g., bioremediation)

Other Applications (diagnostics, microbiome modulation)

Route of Administration

Oral

Topical

Injectable

Other Routes (inhalation, nasal, etc.)

End-User

Hospitals & Specialty Clinics

Research Institutes & Academic Centers

Veterinary Clinics & Animal Health Providers

Other End-Users

Regional Insights

Loading chart…

The Global Phage Therapy Industry market growth is expected to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as increased adoption of phage therapy, favorable policies, and significant investments in research and development. Europe is the second-largest region, with a share of around 30%, driven by growing awareness, established infrastructure, and mature ecosystem.

The fastest-growing region is Asia Pacific, with a projected regional forecast of 15% annual growth rate, driven by rising demographics, improving infrastructure, and increasing investments in healthcare. Latin America and Middle East & Africa are also expected to contribute to the Global Phage Therapy Industry market growth, with shares of around 10% and 5%, respectively, driven by growing demand, expanding healthcare infrastructure, and government initiatives.

Competitive Landscape

The Global Phage Therapy Industry competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by companies that can balance these factors effectively, with a focus on product innovation and regulatory compliance. The Global Phage Therapy Industry key players are investing in research and development to improve their product portfolios and expand their market reach.

Companies in the industry are adopting various strategies to differentiate themselves, including partnerships, product launches, and expansion into new regions. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To address these challenges, companies are focusing on technology, service model, and channel strength to differentiate themselves and maintain a competitive edge. The following companies are examples of this trend:

Armata Pharmaceuticals, Inc. - regional expansion

Adaptive Phage Therapeutics, Inc. - innovation pipeline

Pherecydes Pharma - premium pricing

Intralytix, Inc. - local manufacturing

Locus Biosciences, Inc. - OEM tie-ups

Micreos B.V. - vertical integration

Key Global Phage Therapy Industry Companies15 items

Armata Pharmaceuticals, Inc.

Adaptive Phage Therapeutics, Inc.

Pherecydes Pharma

Intralytix, Inc.

Locus Biosciences, Inc.

Micreos B.V.

Eliava Biopreparations Ltd.

PhagePro Inc.

EnBiotix, Inc.

Technophage SA

Fixed-Phage Ltd.

iNtODEWORLD

Proteon Pharmaceuticals S.A.

Phagelux Inc.

AmpliPhi Biosciences

Market Ecosystem

The Global Phage Therapy Industry ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users and channels. This ecosystem can be broadly segmented into three primary value-creating stages: upstream, where raw materials and technologies are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and services are delivered to end users. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, influencing the overall efficiency and effectiveness of the industry.

Raw material suppliers — provide phage-related components

Technology providers — develop phage therapy technologies

OEMs/manufacturers — produce phage therapy products

System integrators/EPCs — integrate phage therapy systems

Distributors/channel partners — distribute phage therapy products

Regulators/standards bodies — establish industry standards and regulations

End users/buyers — purchase and utilize phage therapy products

The flow of value within the Global Phage Therapy Industry ecosystem is influenced by various control points, including regulatory approvals, technology partnerships, and end-user adoption. Dependency risks, such as input constraints, standards, and approvals, can impact the efficiency of the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can affect the flexibility and adaptability of industry participants. The ecosystem's structure and dynamics can also vary by region, with different areas exhibiting distinct characteristics and requirements that shape the overall value chain analysis.

Recent Industry Insights

The Global Phage Therapy Industry industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between phage therapy companies and research institutions, have accelerated innovation in the field. Notable mergers and acquisitions have also taken place, expanding the reach and capabilities of key players. Furthermore, several product and technology launches have enhanced the industry's offerings, including more effective phage-based treatments and diagnostic tools.

Additionally, regulatory changes have paved the way for increased adoption of phage therapy, with some countries updating their frameworks to accommodate the use of phages as a treatment option. A shift in consumer and enterprise trends has also been observed, with growing awareness and interest in phage therapy driving demand. Funding rounds and expansions have provided the necessary resources for companies to advance their research and development efforts, solidifying the future of the Global Phage Therapy Industry.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Global Phage Therapy Industry market outlook is highly attractive, driven by increasing demand for alternative antimicrobial therapies. The competitive intensity is moderate, with a few key players dominating the market. In the long term, I foresee significant growth opportunities for phage therapy, particularly in treating antibiotic-resistant infections. The innovation landscape is rapidly evolving, with ongoing research and development focused on improving phage therapy efficacy and safety. However, the demand–supply balance is a key concern, with current production capacities struggling to meet growing demand. Key risk factors include regulatory hurdles and potential phage resistance. Overall, my analysis suggests a promising future for the Global Phage Therapy Industry market, with opportunities for investors, researchers, and healthcare providers to collaborate and drive growth.

11 items

1. Executive Summary

2. Global Phage Therapy Industry Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Global Phage Therapy Industry Market Outlook & Forecast (2021-2033) Value (USD Billion)

6.1. Global Global Phage Therapy Industry Market Revenue (USD Billion) and CAGR (%) by Therapy Type (2020-2032)

6.1.1. Monophage Therapy

6.1.2. Phage Cocktails

6.1.3. Engineered/Synthetic Phages

6.1.4. Other Phage-based Modalities

6.2. Global Global Phage Therapy Industry Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.2.1. Infectious Disease Treatment (Human Health)

6.2.2. Veterinary Applications

6.2.3. Food Safety & Agriculture

6.2.4. Environmental Applications (e.g., bioremediation)

6.2.5. Other Applications (diagnostics, microbiome modulation)

6.3. Global Global Phage Therapy Industry Market Revenue (USD Billion) and CAGR (%) by Route of Administration (2020-2032)

6.3.1. Oral

6.3.2. Topical

6.3.3. Injectable

6.3.4. Other Routes (inhalation, nasal, etc.)

6.4. Global Global Phage Therapy Industry Market Revenue (USD Billion) and CAGR (%) by End-User (2020-2032)

6.4.1. Hospitals & Specialty Clinics

6.4.2. Research Institutes & Academic Centers

6.4.3. Veterinary Clinics & Animal Health Providers

6.4.4. Other End-Users

6.5. Global Global Phage Therapy Industry Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

7. Global Global Phage Therapy Industry Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global Global Phage Therapy Industry Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Therapy Type

7.2.3. North America Value (USD Billion) (2020-2032) by Application

7.2.4. North America Value (USD Billion) (2020-2032) by Route of Administration

7.2.5. North America Value (USD Billion) (2020-2032) by End-User

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Therapy Type

7.3.3. South America Value (USD Billion) (2020-2032) by Application

7.3.4. South America Value (USD Billion) (2020-2032) by Route of Administration

7.3.5. South America Value (USD Billion) (2020-2032) by End-User

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Therapy Type

7.4.3. Europe Value (USD Billion) (2020-2032) by Application

7.4.4. Europe Value (USD Billion) (2020-2032) by Route of Administration

7.4.5. Europe Value (USD Billion) (2020-2032) by End-User

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Therapy Type

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.4. Middle East & Africa Value (USD Billion) (2020-2032) by Route of Administration

7.5.5. Middle East & Africa Value (USD Billion) (2020-2032) by End-User

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Therapy Type

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.4. Asia Pacific Value (USD Billion) (2020-2032) by Route of Administration

7.6.5. Asia Pacific Value (USD Billion) (2020-2032) by End-User

8. Global Global Phage Therapy Industry Market Competition by Key Manufacturers

8.1. Global Global Phage Therapy Industry Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Global Phage Therapy Industry: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Armata Pharmaceuticals, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Adaptive Phage Therapeutics, Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Pherecydes Pharma

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Intralytix, Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Locus Biosciences, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Micreos B.V.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Eliava Biopreparations Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. PhagePro Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. EnBiotix, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Technophage SA

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Fixed-Phage Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. iNtODEWORLD

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Proteon Pharmaceuticals S.A.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Phagelux Inc.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. AmpliPhi Biosciences

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

32 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Global Phage Therapy Industry Market

Figure 4: Global Global Phage Therapy Industry Market: Drivers

Figure 5: Global Global Phage Therapy Industry Market: Challenges

Figure 6: Global Global Phage Therapy Industry Market: Trends

Figure 7: Global Global Phage Therapy Industry Market: Opportunity

Figure 8: Global Global Phage Therapy Industry Market: Restraint

Figure 9: Global Global Phage Therapy Industry Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Therapy Type

Figure 11: Global Market Share (%) By Therapy Type (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Value (USD Billion) (2020-2024) By Route of Administration

Figure 15: Global Market Share (%) By Route of Administration (2024)

Figure 16: Global Market Value (USD Billion) (2020-2024) By End-User

Figure 17: Global Market Share (%) By End-User (2024)

Figure 18: Global Global Phage Therapy Industry Market Value (USD Billion) By Region

Figure 19: Global Global Phage Therapy Industry Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Billion) (2025-2032) By Therapy Type

Figure 23: Global Market Share (%) By Therapy Type (2032)

Figure 24: Global Market Value (USD Billion) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Market Value (USD Billion) (2025-2032) By Route of Administration

Figure 27: Global Market Share (%) By Route of Administration (2032)

Figure 28: Global Market Value (USD Billion) (2025-2032) By End-User

Figure 29: Global Market Share (%) By End-User (2032)

Figure 30: Global Global Phage Therapy Industry Market Value (USD Billion) By Region

Figure 31: Global Global Phage Therapy Industry Market Share (%) By: Regions (2032)

Figure 32: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Global Phage Therapy Industry Revenue (USD Billion) And Cagr (%) By Therapy Type (2020-2032)

Table 3: Global Global Phage Therapy Industry Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 4: Global Global Phage Therapy Industry Revenue (USD Billion) And Cagr (%) By Route of Administration (2020-2032)

Table 5: Global Global Phage Therapy Industry Revenue (USD Billion) And Cagr (%) By End-User (2020-2032)

Table 6: Global Global Phage Therapy Industry Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 7: Global Market Value (USD Billion) (2020-2024) By Therapy Type

Table 8: Global Market Share (%) By Therapy Type (2024)

Table 9: Global Market Value (USD Billion) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Value (USD Billion) (2020-2024) By Route of Administration

Table 12: Global Market Share (%) By Route of Administration (2024)

Table 13: Global Market Value (USD Billion) (2020-2024) By End-User

Table 14: Global Market Share (%) By End-User (2024)

Table 15: Global Global Phage Therapy Industry Market Value (USD Billion) By Region

Table 16: Global Global Phage Therapy Industry Market Share (%) By Region

Table 17: North America Market Value (USD Billion) (2020-2024) By Country

Table 18: North America Market Value (USD Billion) (2020-2024) By Therapy Type

Table 19: North America Market Value (USD Billion) (2020-2024) By Application

Table 20: North America Market Value (USD Billion) (2020-2024) By Route of Administration

Table 21: North America Market Value (USD Billion) (2020-2024) By End-User

Table 22: Europe Market Value (USD Billion) (2020-2024) By Country

Table 23: Europe Market Value (USD Billion) (2020-2024) By Therapy Type

Table 24: Europe Market Value (USD Billion) (2020-2024) By Application

Table 25: Europe Market Value (USD Billion) (2020-2024) By Route of Administration

Table 26: Europe Market Value (USD Billion) (2020-2024) By End-User

Table 27: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 28: Asia Pacific Market Value (USD Billion) (2020-2024) By Therapy Type

Table 29: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 30: Asia Pacific Market Value (USD Billion) (2020-2024) By Route of Administration

Table 31: Asia Pacific Market Value (USD Billion) (2020-2024) By End-User

Table 32: South America Market Value (USD Billion) (2020-2024) By Country

Table 33: South America Market Value (USD Billion) (2020-2024) By Therapy Type

Table 34: South America Market Value (USD Billion) (2020-2024) By Application

Table 35: South America Market Value (USD Billion) (2020-2024) By Route of Administration

Table 36: South America Market Value (USD Billion) (2020-2024) By End-User

Table 37: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 38: Middle East & Africa Market Value (USD Billion) (2020-2024) By Therapy Type

Table 39: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 40: Middle East & Africa Market Value (USD Billion) (2020-2024) By Route of Administration

Table 41: Middle East & Africa Market Value (USD Billion) (2020-2024) By End-User

Table 42: Global Global Phage Therapy Industry Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 43: Global Global Phage Therapy Industry Market: Profiled Players Head Office And Area Served

Table 44: Key Players Global Global Phage Therapy Industry Market:

Table 45: Mergers & Acquisitions, Expansion Plans

Table 46: Armata Pharmaceuticals, Inc. Basic Information And Sales Area

Table 47: Armata Pharmaceuticals, Inc.. Products Portfolio

Table 48: Adaptive Phage Therapeutics, Inc. Basic Information And Sales Area

Table 49: Adaptive Phage Therapeutics, Inc.. Products Portfolio

Table 50: Pherecydes Pharma Basic Information And Sales Area

Table 51: Pherecydes Pharma. Products Portfolio

Table 52: Intralytix, Inc. Basic Information And Sales Area

Table 53: Intralytix, Inc.. Products Portfolio

Table 54: Locus Biosciences, Inc. Basic Information And Sales Area

Table 55: Locus Biosciences, Inc.. Products Portfolio

Table 56: Micreos B.V. Basic Information And Sales Area

Table 57: Micreos B.V.. Products Portfolio

Table 58: Eliava Biopreparations Ltd. Basic Information And Sales Area

Table 59: Eliava Biopreparations Ltd.. Products Portfolio

Table 60: PhagePro Inc. Basic Information And Sales Area

Table 61: PhagePro Inc.. Products Portfolio

Table 62: EnBiotix, Inc. Basic Information And Sales Area

Table 63: EnBiotix, Inc.. Products Portfolio

Table 64: Technophage SA Basic Information And Sales Area

Table 65: Technophage SA. Products Portfolio

Table 66: Fixed-Phage Ltd. Basic Information And Sales Area

Table 67: Fixed-Phage Ltd.. Products Portfolio

Table 68: iNtODEWORLD Basic Information And Sales Area

Table 69: iNtODEWORLD. Products Portfolio

Table 70: Proteon Pharmaceuticals S.A. Basic Information And Sales Area

Table 71: Proteon Pharmaceuticals S.A.. Products Portfolio

Table 72: Phagelux Inc. Basic Information And Sales Area

Table 73: Phagelux Inc.. Products Portfolio

Table 74: AmpliPhi Biosciences Basic Information And Sales Area

Table 75: AmpliPhi Biosciences. Products Portfolio

Table 76: Global Market Value (USD Billion) (2025-2032) By Therapy Type

Table 77: Global Market Share (%) By Therapy Type (2032)

Table 78: Global Market Value (USD Billion) (2025-2032) By Application

Table 79: Global Market Share (%) By Application (2032)

Table 80: Global Market Value (USD Billion) (2025-2032) By Route of Administration

Table 81: Global Market Share (%) By Route of Administration (2032)

Table 82: Global Market Value (USD Billion) (2025-2032) By End-User

Table 83: Global Market Share (%) By End-User (2032)

Table 84: Global Global Phage Therapy Industry Market Value (USD Billion) By Region

Table 85: Global Global Phage Therapy Industry Market Share (%) By Region (2025-2032)

Table 86: North America Market Value (USD Billion) (2025-2032) By Country

Table 87: North America Market Value (USD Billion) (2025-2032) By Therapy Type

Table 88: North America Market Value (USD Billion) (2025-2032) By Application

Table 89: North America Market Value (USD Billion) (2025-2032) By Route of Administration

Table 90: North America Market Value (USD Billion) (2025-2032) By End-User

Table 91: Europe Market Value (USD Billion) (2025-2032) By Country

Table 92: Europe Market Value (USD Billion) (2025-2032) By Therapy Type

Table 93: Europe Market Value (USD Billion) (2025-2032) By Application

Table 94: Europe Market Value (USD Billion) (2025-2032) By Route of Administration

Table 95: Europe Market Value (USD Billion) (2025-2032) By End-User

Table 96: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 97: Asia Pacific Market Value (USD Billion) (2025-2032) By Therapy Type

Table 98: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Billion) (2025-2032) By Route of Administration

Table 100: Asia Pacific Market Value (USD Billion) (2025-2032) By End-User

Table 101: South America Market Value (USD Billion) (2025-2032) By Country

Table 102: South America Market Value (USD Billion) (2025-2032) By Therapy Type

Table 103: South America Market Value (USD Billion) (2025-2032) By Application

Table 104: South America Market Value (USD Billion) (2025-2032) By Route of Administration

Table 105: South America Market Value (USD Billion) (2025-2032) By End-User

Table 106: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 107: Middle East & Africa Market Value (USD Billion) (2025-2032) By Therapy Type

Table 108: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Billion) (2025-2032) By Route of Administration

Table 110: Middle East & Africa Market Value (USD Billion) (2025-2032) By End-User

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Global Phage Therapy Industry Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	86.30 billion
Revenue forecast in 2033	307.21 billion
Growth rate	CAGR of 17.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Therapy Type, Application, Route of Administration, End-User
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Armata Pharmaceuticals, Inc.; Adaptive Phage Therapeutics, Inc.; Pherecydes Pharma; Intralytix, Inc.; Locus Biosciences, Inc.; Micreos B.V.; Eliava Biopreparations Ltd.; PhagePro Inc.; EnBiotix, Inc.; Technophage SA; Fixed-Phage Ltd.; iNtODEWORLD; Proteon Pharmaceuticals S.A.; Phagelux Inc.; AmpliPhi Biosciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options